Search This Blog

Tuesday, February 18, 2020

Amedisys EPS beats by $0.01, misses on revenue

Amedisys  (NASDAQ:AMED): Q4 Non-GAAP EPS of $0.94 beats by $0.01; GAAP EPS of $0.83 misses by $0.09.

Revenue of $500.68M (+15.3% Y/Y) misses by $10.9M.

Shares -0.54%.



No comments:

Post a Comment

Note: Only a member of this blog may post a comment.